IP Library › Granted Patent US 11,771,311
Granted Patent B2
US 11,771,311 · App. 17/384,101 · Granted Oct 3, 2023

Systems and methods for collecting and screening of pancreatic secretions

Inventors: Xiaodong Duan (Pleasanton, CA); Guohua Xiao (Plano, TX); Kevin Rubey (Ventura, CA)
Assignee: AnX Robotica Corp
A61B1/041A61B1/015A61B1/05A61B1/273
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,771,311
App. No.
17/384,101
Granted
Oct 3, 2023
Kind
B2
Abstract

Disclosed here are systems and methods for collecting and/or screening of a pancreatic secretion, using a capsule endoscope comprising an imaging system and a trypsin sensor, and a tether coupled to the capsule endoscope.

Claims (38)

1. A system, comprising:

a capsule endoscope comprising:

an imaging system; and

a trypsin sensor comprising:

a substrate comprising a polymeric film, and

a dye selected from the group consisting of bromocresol purple dye, 3′,5,5′-tetramethyl benzidine dye, triarylmethane dye, xylenol orange dye, and metal complex dye,

wherein the trypsin sensor is configured to detect trypsin in a fluid that is in contact with the trypsin sensor, and wherein the polymeric film comprises bromobutane and vinylimidazole at a molar ratio of between 2:1 to 1:1 bromobutane to vinylimidazole; and

a tether comprising a flexible member comprising a lumen, wherein the flexible member is in fluidic communication with the capsule endoscope.

2. The system of claim 1 , wherein the substrate and the dye form a trypsin detection film.

3. The system of claim 1 , wherein the trypsin sensor is configured to detect fluid comprising a pancreatic secretion, thereby identifying the location of duodenal papilla.

4. The system of claim 3 , wherein the system is configured to withdraw a sample comprising the pancreatic secretion.

5. The system of claim 1 , wherein the substrate and the dye form a stable film.

6. The system of claim 1 , wherein the dye changes color when in contact with fluid having trypsin present above a predetermined concentration.

7. The system of claim 6 , wherein the predetermined concentration of the trypsin in the fluid is at least about 300 μg/mL.

8. The system of claim 1 , wherein the polymeric film further comprises acrylonitrile.

9. The system of claim 8 , wherein the mass of acrylonitrile is greater than or equal to the sum of the masses of bromobutane and vinylimidazole.

10. The system of claim 1 , further comprising a vacuum source arranged in fluidic communication with the lumen.

11. The system of claim 10 , wherein the vacuum source comprises a syringe or pump.

12. The system of claim 1 , wherein the tether comprises a clamp configured to engage the capsule endoscope.

13. The system of claim 12 , wherein the clamp is configured to releasably engage the capsule endoscope.

14. The system of claim 12 , wherein the clamp comprises a port configured to be in fluidic communication with the lumen and with an environment outside the clamp while the clamp is engaged with the capsule endoscope.

15. The system of claim 1 , wherein the capsule endoscope is magnetically controllable.

16. A method, comprising:

advancing a capsule endoscope into a gastrointestinal tract of a patient, wherein the capsule endoscope comprises an imaging system and a trypsin sensor comprising a substrate and a dye selected from the group consisting of bromocresol purple dye, 3′,5,5′-tetramethyl benzidine dye, triarylmethane dye, xylenol orange dye, and metal complex dye, wherein the capsule endoscope is in fluidic communication with a tether comprising a flexible member with a lumen, and wherein the substrate comprises a polymeric film comprising bromobutane and vinylimidazole at a molar ratio between 2:1 and 1:1 bromobutane to vinylimidazole;

positioning the capsule endoscope at a region of interest;

detecting trypsin in a fluid that is in contact with the trypsin sensor; and

withdrawing a sample from the region of interest through the lumen.

17. A system, comprising:

a capsule endoscope comprising:

an imaging system; and

a trypsin sensor comprising:

a substrate comprising a polymeric film, and

a dye selected from the group consisting of bromocresol purple dye, 3′,5,5′-tetramethyl benzidine dye, triarylmethane dye, xylenol orange dye, and metal complex dye,

wherein the trypsin sensor is configured to detect trypsin in a fluid that is in contact with the trypsin sensor, wherein the polymeric film comprises bromobutane, vinylimidazole, and acrylonitrile, and wherein the mass of acrylonitrile is greater than or equal to the sum of the masses of bromobutane and vinylimidazole; and

a tether comprising a flexible member comprising a lumen, wherein the flexible member is in fluidic communication with the capsule endoscope.

18. The system of claim 17 , wherein the trypsin sensor is configured to detect fluid comprising a pancreatic secretion, thereby identifying the location of duodenal papilla.

19. The system of claim 17 , wherein the substrate and the dye form a stable film.

20. The system of claim 17 , wherein the dye changes color when in contact with fluid having trypsin present above a predetermined concentration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2021
From: DUAN, XIAODONG; XIAO, GUOHUA; RUBEY, KEVIN
To: ANX ROBOTICA CORP
Reel/Frame 058096/0303 →
Priority Claims (1)
CN 202010725938.5 · Jul 24, 2020 · national
Continuity (1)
Related Publication 20220022736A1 · Jan 27, 2022
Cited By (1)
US 1,060,669